Is obesity a major cause of chronic kidney disease?

被引:164
作者
Hall, JE
Henegar, JR
Dwyer, TM
Liu, JK
da Silva, AA
Kuo, JJ
Tallam, L
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA
来源
ADVANCES IN RENAL REPLACEMENT THERAPY | 2004年 / 11卷 / 01期
关键词
end-stage renal disease; type II diabetes; hypertension; sympathetic nervous system; renin-angiotensin system; glomerular filtration rate; lipids; insulin resistance; inflammation;
D O I
10.1053/j.arrt.2003.10.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Excess weight gain is a major risk factor for essential hypertension and for end-stage renal disease (ESRD). Obesity raises blood pressure by increasing renal tubular sodium reabsorption, impairing pressure natriuresis, and causing volume expansion because of activation of the sympathetic nervous system and renin-angiotensin system and by physical compression of the kidneys, especially when visceral obesity is present. Obesity also causes renal vasodilation and glomerular hyperfiltration that initially serve as, compensatory mechanisms to maintain sodium balance in the face of increased tubular reabsorption. In the long-term, however, these changes, along with the increased systemic arterial pressure, create a hemodynamic burden on the kidneys that causes glomerular injury. With prolonged obesity, there is increasing urinary protein excretion and gradual loss of nephron function that worsens with time and exacerbates hypertension. With the worsening of metabolic disturbances and the development of type II diabetes in some obese patients, kidney disease progresses much more rapidly. Weight reduction is an essential first step in the management of obesity, hypertension, and kidney disease. Special considerations for the obese patient, in addition to adequately controlling the blood pressure, include correction of the metabolic abnormalities and protection of the kidneys from further injury. (C) 2004 by the National Kidney Foundation, Inc.
引用
收藏
页码:41 / 54
页数:14
相关论文
共 78 条
  • [1] Overweight and sympathetic overactivity in black Americans
    Abate, NI
    Mansour, YH
    Tuncel, M
    Arbique, D
    Chavoshan, B
    Kizilbash, A
    Howell-Stampley, T
    Vongpatanasin, W
    Victor, RG
    [J]. HYPERTENSION, 2001, 38 (03) : 379 - 383
  • [2] ALDEMAN RD, 2001, J PEDIATR, V138, P481
  • [3] Alexander J, 1979, US DHEW PUBLICATION, V70-1631, P61
  • [4] Hypertension in obese Zucker rats - Role of angiotensin II and adrenergic activity
    AlonsoGalicia, M
    Brands, MW
    Zappe, DH
    Hall, JE
    [J]. HYPERTENSION, 1996, 28 (06) : 1047 - 1054
  • [5] Sympathetic neural activation in visceral obesity
    Alvarez, GE
    Beske, SD
    Ballard, TP
    Davy, KP
    [J]. CIRCULATION, 2002, 106 (20) : 2533 - 2536
  • [6] Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis
    Bonnet, F
    Deprele, C
    Sassolas, A
    Moulin, P
    Alamartine, E
    Berthezène, F
    Berthoux, F
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) : 720 - 727
  • [7] Interactions of transforming growth factor-β and angiotensin II in renal fibrosis
    Border, WA
    Noble, NA
    [J]. HYPERTENSION, 1998, 31 (01) : 181 - 188
  • [8] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [9] Chronic cardiovascular and renal actions of leptin - Role of adrenergic activity
    Carlyle, M
    Jones, OB
    Kuo, JJ
    Hall, JE
    [J]. HYPERTENSION, 2002, 39 (02) : 496 - 501
  • [10] Glomerular hemodynamics in severe obesity
    Chagnac, A
    Weinstein, T
    Korzets, A
    Ramadan, E
    Hirsch, J
    Gafter, U
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (05) : F817 - F822